(Boursier.com) — Valneva a company specializing in vaccines, announces today that its supervisory board has renewed the mandates of the members of the management board for an additional period of three years, which will begin at the end of the General Meeting (GM) of the company in June. 2022.
The current mandates of Thomas Lingelbach, Chairman of the Management Board and Chief Executive Officer, Franck Grimaud, Managing Director and Chief Business Officer, Peter Bühler, Financial Director, Juan Carlos Jaramillo, Medical Director and Frédéric Jacotot, Legal Director and Corporate Secretary, are coming to an end during this GA.
©2022 Boursier.com